Parkinson's Disease Treatments
Parkinson's Disease Treatments market is segmented by players, region (country), by Type and by A ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Computational Immunology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Cancer Diagnosis & Therapy 1.2.3 Reverse Vaccinology 1.2.4 Immune System Modeling 1.3 Market by Application 1.3.1 Global Computational Immunology Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Allergy Prediction Databases 1.3.3 Analysis Resource Database 1.3.4 International Immunogenetics System 1.3.5 The Ontology of Immune Epitopes 1.3.6 Immune Epitope Database 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Computational Immunology Market Perspective (2017-2028) 2.2 Computational Immunology Growth Trends by Region 2.2.1 Computational Immunology Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Computational Immunology Historic Market Size by Region (2017-2022) 2.2.3 Computational Immunology Forecasted Market Size by Region (2023-2028) 2.3 Computational Immunology Market Dynamics 2.3.1 Computational Immunology Industry Trends 2.3.2 Computational Immunology Market Drivers 2.3.3 Computational Immunology Market Challenges 2.3.4 Computational Immunology Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Computational Immunology Players by Revenue 3.1.1 Global Top Computational Immunology Players by Revenue (2017-2022) 3.1.2 Global Computational Immunology Revenue Market Share by Players (2017-2022) 3.2 Global Computational Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Computational Immunology Revenue 3.4 Global Computational Immunology Market Concentration Ratio 3.4.1 Global Computational Immunology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Computational Immunology Revenue in 2021 3.5 Computational Immunology Key Players Head office and Area Served 3.6 Key Players Computational Immunology Product Solution and Service 3.7 Date of Enter into Computational Immunology Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Computational Immunology Breakdown Data by Type 4.1 Global Computational Immunology Historic Market Size by Type (2017-2022) 4.2 Global Computational Immunology Forecasted Market Size by Type (2023-2028) 5 Computational Immunology Breakdown Data by Application 5.1 Global Computational Immunology Historic Market Size by Application (2017-2022) 5.2 Global Computational Immunology Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Computational Immunology Market Size (2017-2028) 6.2 North America Computational Immunology Market Size by Country (2017-2022) 6.3 North America Computational Immunology Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Computational Immunology Market Size (2017-2028) 7.2 Europe Computational Immunology Market Size by Country (2017-2022) 7.3 Europe Computational Immunology Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Computational Immunology Market Size (2017-2028) 8.2 Asia-Pacific Computational Immunology Market Size by Country (2017-2022) 8.3 Asia-Pacific Computational Immunology Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Computational Immunology Market Size (2017-2028) 9.2 Latin America Computational Immunology Market Size by Country (2017-2022) 9.3 Latin America Computational Immunology Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Computational Immunology Market Size (2017-2028) 10.2 Middle East & Africa Computational Immunology Market Size by Country (2017-2022) 10.3 Middle East & Africa Computational Immunology Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 EpiVax 11.1.1 EpiVax Company Detail 11.1.2 EpiVax Business Overview 11.1.3 EpiVax Computational Immunology Introduction 11.1.4 EpiVax Revenue in Computational Immunology Business (2017-2022) 11.1.5 EpiVax Recent Development 11.2 Novozymes Biopharma 11.2.1 Novozymes Biopharma Company Detail 11.2.2 Novozymes Biopharma Business Overview 11.2.3 Novozymes Biopharma Computational Immunology Introduction 11.2.4 Novozymes Biopharma Revenue in Computational Immunology Business (2017-2022) 11.2.5 Novozymes Biopharma Recent Development 11.3 ioGenetics 11.3.1 ioGenetics Company Detail 11.3.2 ioGenetics Business Overview 11.3.3 ioGenetics Computational Immunology Introduction 11.3.4 ioGenetics Revenue in Computational Immunology Business (2017-2022) 11.3.5 ioGenetics Recent Development 11.4 International Society of Vaccines 11.4.1 International Society of Vaccines Company Detail 11.4.2 International Society of Vaccines Business Overview 11.4.3 International Society of Vaccines Computational Immunology Introduction 11.4.4 International Society of Vaccines Revenue in Computational Immunology Business (2017-2022) 11.4.5 International Society of Vaccines Recent Development 11.5 IMGT 11.5.1 IMGT Company Detail 11.5.2 IMGT Business Overview 11.5.3 IMGT Computational Immunology Introduction 11.5.4 IMGT Revenue in Computational Immunology Business (2017-2022) 11.5.5 IMGT Recent Development 11.6 Dassault Systemes 11.6.1 Dassault Systemes Company Detail 11.6.2 Dassault Systemes Business Overview 11.6.3 Dassault Systemes Computational Immunology Introduction 11.6.4 Dassault Systemes Revenue in Computational Immunology Business (2017-2022) 11.6.5 Dassault Systemes Recent Development 11.7 Certara 11.7.1 Certara Company Detail 11.7.2 Certara Business Overview 11.7.3 Certara Computational Immunology Introduction 11.7.4 Certara Revenue in Computational Immunology Business (2017-2022) 11.7.5 Certara Recent Development 11.8 Chemical Computing Group 11.8.1 Chemical Computing Group Company Detail 11.8.2 Chemical Computing Group Business Overview 11.8.3 Chemical Computing Group Computational Immunology Introduction 11.8.4 Chemical Computing Group Revenue in Computational Immunology Business (2017-2022) 11.8.5 Chemical Computing Group Recent Development 11.9 Compugen 11.9.1 Compugen Company Detail 11.9.2 Compugen Business Overview 11.9.3 Compugen Computational Immunology Introduction 11.9.4 Compugen Revenue in Computational Immunology Business (2017-2022) 11.9.5 Compugen Recent Development 11.10 Genedata AG 11.10.1 Genedata AG Company Detail 11.10.2 Genedata AG Business Overview 11.10.3 Genedata AG Computational Immunology Introduction 11.10.4 Genedata AG Revenue in Computational Immunology Business (2017-2022) 11.10.5 Genedata AG Recent Development 11.11 Insilico Biotechnology AG 11.11.1 Insilico Biotechnology AG Company Detail 11.11.2 Insilico Biotechnology AG Business Overview 11.11.3 Insilico Biotechnology AG Computational Immunology Introduction 11.11.4 Insilico Biotechnology AG Revenue in Computational Immunology Business (2017-2022) 11.11.5 Insilico Biotechnology AG Recent Development 11.12 Leadscope Inc 11.12.1 Leadscope Inc Company Detail 11.12.2 Leadscope Inc Business Overview 11.12.3 Leadscope Inc Computational Immunology Introduction 11.12.4 Leadscope Inc Revenue in Computational Immunology Business (2017-2022) 11.12.5 Leadscope Inc Recent Development 11.13 Nimbus Discovery 11.13.1 Nimbus Discovery Company Detail 11.13.2 Nimbus Discovery Business Overview 11.13.3 Nimbus Discovery Computational Immunology Introduction 11.13.4 Nimbus Discovery Revenue in Computational Immunology Business (2017-2022) 11.13.5 Nimbus Discovery Recent Development 11.14 Strand Life Sciences 11.14.1 Strand Life Sciences Company Detail 11.14.2 Strand Life Sciences Business Overview 11.14.3 Strand Life Sciences Computational Immunology Introduction 11.14.4 Strand Life Sciences Revenue in Computational Immunology Business (2017-2022) 11.14.5 Strand Life Sciences Recent Development 11.15 Schrodinger 11.15.1 Schrodinger Company Detail 11.15.2 Schrodinger Business Overview 11.15.3 Schrodinger Computational Immunology Introduction 11.15.4 Schrodinger Revenue in Computational Immunology Business (2017-2022) 11.15.5 Schrodinger Recent Development 11.16 Simulation Plus 11.16.1 Simulation Plus Company Detail 11.16.2 Simulation Plus Business Overview 11.16.3 Simulation Plus Computational Immunology Introduction 11.16.4 Simulation Plus Revenue in Computational Immunology Business (2017-2022) 11.16.5 Simulation Plus Recent Development 11.17 Rosa & Co 11.17.1 Rosa & Co Company Detail 11.17.2 Rosa & Co Business Overview 11.17.3 Rosa & Co Computational Immunology Introduction 11.17.4 Rosa & Co Revenue in Computational Immunology Business (2017-2022) 11.17.5 Rosa & Co Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Computational Immunology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Cancer Diagnosis & Therapy Table 3. Key Players of Reverse Vaccinology Table 4. Key Players of Immune System Modeling Table 5. Global Computational Immunology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Computational Immunology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Computational Immunology Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Computational Immunology Market Share by Region (2017-2022) Table 9. Global Computational Immunology Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Computational Immunology Market Share by Region (2023-2028) Table 11. Computational Immunology Market Trends Table 12. Computational Immunology Market Drivers Table 13. Computational Immunology Market Challenges Table 14. Computational Immunology Market Restraints Table 15. Global Computational Immunology Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Computational Immunology Market Share by Players (2017-2022) Table 17. Global Top Computational Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Immunology as of 2021) Table 18. Ranking of Global Top Computational Immunology Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Computational Immunology Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Computational Immunology Product Solution and Service Table 22. Date of Enter into Computational Immunology Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Computational Immunology Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Computational Immunology Revenue Market Share by Type (2017-2022) Table 26. Global Computational Immunology Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Computational Immunology Revenue Market Share by Type (2023-2028) Table 28. Global Computational Immunology Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Computational Immunology Revenue Market Share by Application (2017-2022) Table 30. Global Computational Immunology Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Computational Immunology Revenue Market Share by Application (2023-2028) Table 32. North America Computational Immunology Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Computational Immunology Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Computational Immunology Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Computational Immunology Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Computational Immunology Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Computational Immunology Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Computational Immunology Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Computational Immunology Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Computational Immunology Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Computational Immunology Market Size by Country (2023-2028) & (US$ Million) Table 42. EpiVax Company Detail Table 43. EpiVax Business Overview Table 44. EpiVax Computational Immunology Product Table 45. EpiVax Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 46. EpiVax Recent Development Table 47. Novozymes Biopharma Company Detail Table 48. Novozymes Biopharma Business Overview Table 49. Novozymes Biopharma Computational Immunology Product Table 50. Novozymes Biopharma Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 51. Novozymes Biopharma Recent Development Table 52. ioGenetics Company Detail Table 53. ioGenetics Business Overview Table 54. ioGenetics Computational Immunology Product Table 55. ioGenetics Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 56. ioGenetics Recent Development Table 57. International Society of Vaccines Company Detail Table 58. International Society of Vaccines Business Overview Table 59. International Society of Vaccines Computational Immunology Product Table 60. International Society of Vaccines Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 61. International Society of Vaccines Recent Development Table 62. IMGT Company Detail Table 63. IMGT Business Overview Table 64. IMGT Computational Immunology Product Table 65. IMGT Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 66. IMGT Recent Development Table 67. Dassault Systemes Company Detail Table 68. Dassault Systemes Business Overview Table 69. Dassault Systemes Computational Immunology Product Table 70. Dassault Systemes Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 71. Dassault Systemes Recent Development Table 72. Certara Company Detail Table 73. Certara Business Overview Table 74. Certara Computational Immunology Product Table 75. Certara Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 76. Certara Recent Development Table 77. Chemical Computing Group Company Detail Table 78. Chemical Computing Group Business Overview Table 79. Chemical Computing Group Computational Immunology Product Table 80. Chemical Computing Group Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 81. Chemical Computing Group Recent Development Table 82. Compugen Company Detail Table 83. Compugen Business Overview Table 84. Compugen Computational Immunology Product Table 85. Compugen Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 86. Compugen Recent Development Table 87. Genedata AG Company Detail Table 88. Genedata AG Business Overview Table 89. Genedata AG Computational Immunology Product Table 90. Genedata AG Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 91. Genedata AG Recent Development Table 92. Insilico Biotechnology AG Company Detail Table 93. Insilico Biotechnology AG Business Overview Table 94. Insilico Biotechnology AG Computational ImmunologyProduct Table 95. Insilico Biotechnology AG Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 96. Insilico Biotechnology AG Recent Development Table 97. Leadscope Inc Company Detail Table 98. Leadscope Inc Business Overview Table 99. Leadscope Inc Computational ImmunologyProduct Table 100. Leadscope Inc Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 101. Leadscope Inc Recent Development Table 102. Nimbus Discovery Company Detail Table 103. Nimbus Discovery Business Overview Table 104. Nimbus Discovery Computational ImmunologyProduct Table 105. Nimbus Discovery Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 106. Nimbus Discovery Recent Development Table 107. Strand Life Sciences Company Detail Table 108. Strand Life Sciences Business Overview Table 109. Strand Life Sciences Computational ImmunologyProduct Table 110. Strand Life Sciences Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 111. Strand Life Sciences Recent Development Table 112. Schrodinger Company Detail Table 113. Schrodinger Business Overview Table 114. Schrodinger Computational ImmunologyProduct Table 115. Schrodinger Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 116. Schrodinger Recent Development Table 117. Simulation Plus Company Detail Table 118. Simulation Plus Business Overview Table 119. Simulation Plus Computational ImmunologyProduct Table 120. Simulation Plus Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 121. Simulation Plus Recent Development Table 122. Rosa & Co Company Detail Table 123. Rosa & Co Business Overview Table 124. Rosa & Co Computational ImmunologyProduct Table 125. Rosa & Co Revenue in Computational Immunology Business (2017-2022) & (US$ Million) Table 126. Rosa & Co Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Computational Immunology Market Share by Type: 2021 VS 2028 Figure 2. Cancer Diagnosis & Therapy Features Figure 3. Reverse Vaccinology Features Figure 4. Immune System Modeling Features Figure 5. Global Computational Immunology Market Share by Application in 2021 & 2028 Figure 6. Allergy Prediction Databases Case Studies Figure 7. Analysis Resource Database Case Studies Figure 8. International Immunogenetics System Case Studies Figure 9. The Ontology of Immune Epitopes Case Studies Figure 10. Immune Epitope Database Case Studies Figure 11. Computational Immunology Report Years Considered Figure 12. Global Computational Immunology Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Computational Immunology Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Computational Immunology Market Share by Region: 2021 VS 2028 Figure 15. Global Computational Immunology Market Share by Players in 2021 Figure 16. Global Top Computational Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Immunology as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Computational Immunology Revenue in 2021 Figure 18. North America Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Computational Immunology Market Share by Country (2017-2028) Figure 20. United States Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Computational Immunology Market Share by Country (2017-2028) Figure 24. Germany Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Computational Immunology Market Share by Region (2017-2028) Figure 32. China Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Computational Immunology Market Share by Country (2017-2028) Figure 40. Mexico Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Computational Immunology Market Share by Country (2017-2028) Figure 44. Turkey Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Computational Immunology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. EpiVax Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 47. Novozymes Biopharma Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 48. ioGenetics Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 49. International Society of Vaccines Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 50. IMGT Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 51. Dassault Systemes Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 52. Certara Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 53. Chemical Computing Group Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 54. Compugen Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 55. Genedata AG Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 56. Insilico Biotechnology AG Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 57. Leadscope Inc Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 58. Nimbus Discovery Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 59. Strand Life Sciences Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 60. Schrodinger Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 61. Simulation Plus Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 62. Rosa & Co Revenue Growth Rate in Computational Immunology Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed
EpiVax Novozymes Biopharma ioGenetics International Society of Vaccines IMGT Dassault Systemes Certara Chemical Computing Group Compugen Genedata AG Insilico Biotechnology AG Leadscope Inc Nimbus Discovery Strand Life Sciences Schrodinger Simulation Plus Rosa & Co
Parkinson's Disease Treatments market is segmented by players, region (country), by Type and by A ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Pharmaceutical Solid Dosage Contract Manufacturing market is segmented by players, region (countr ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More